Article Details
Retrieved on: 2021-08-10 11:56:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities initiated coverage on shares of Iovance Biotherapeutics in a research report on Monday, May 3rd. They issued a "buy" rating and a ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here